Korn E L, Baumrind S
Biometric Research Branch, National Cancer Institute, Bethesda, Maryland 20892.
Lancet. 1991 Jan 19;337(8734):149-52. doi: 10.1016/0140-6736(91)90809-4.
The standard design for randomised clinical trials may be inappropriate when the clinician believes that one of the treatments being tested is superior for the patient, or when the clinician has a preference for one of the treatments. For such instances the suggestion is that the patient is randomly allocated to treatment only when there is clinical disagreement about treatment of choice for that patient, and then the patient is assigned to a clinician who had thought that the regimen allocated is the one most appropriate for that patient.
当临床医生认为所测试的某种治疗方法对患者更有利,或者临床医生对其中一种治疗方法有所偏好时,随机临床试验的标准设计可能并不适用。对于这种情况,建议仅在针对该患者的治疗选择存在临床分歧时,才将患者随机分配接受治疗,然后将患者分配给认为所分配的治疗方案最适合该患者的临床医生。